Copyright Reports & Markets. All rights reserved.

Global Cholesterol Management Devices Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cholesterol Management Devices Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cholesterol Management Devices Market Size Growth Rate by Product
      • 1.4.2 Monitors
      • 1.4.3 Wrist Monitors
      • 1.4.4 Small Portable Instruments
      • 1.4.5 Meters
      • 1.4.6 Wireless Systems
    • 1.5 Market by End User
      • 1.5.1 Global Cholesterol Management Devices Market Size Growth Rate by End User
      • 1.5.2 Home Healthcare
      • 1.5.3 Hospitals
      • 1.5.4 Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cholesterol Management Devices Market Size
      • 2.1.1 Global Cholesterol Management Devices Revenue 2014-2025
      • 2.1.2 Global Cholesterol Management Devices Sales 2014-2025
    • 2.2 Cholesterol Management Devices Growth Rate by Regions
      • 2.2.1 Global Cholesterol Management Devices Sales by Regions
      • 2.2.2 Global Cholesterol Management Devices Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cholesterol Management Devices Sales by Manufacturers
      • 3.1.1 Cholesterol Management Devices Sales by Manufacturers
      • 3.1.2 Cholesterol Management Devices Sales Market Share by Manufacturers
      • 3.1.3 Global Cholesterol Management Devices Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cholesterol Management Devices Revenue by Manufacturers
      • 3.2.1 Cholesterol Management Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cholesterol Management Devices Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cholesterol Management Devices Price by Manufacturers
    • 3.4 Cholesterol Management Devices Manufacturing Base Distribution, Product Types
      • 3.4.1 Cholesterol Management Devices Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cholesterol Management Devices Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cholesterol Management Devices Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cholesterol Management Devices Sales by Product
    • 4.2 Global Cholesterol Management Devices Revenue by Product
    • 4.3 Cholesterol Management Devices Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cholesterol Management Devices Breakdown Data by End User

    6 North America

    • 6.1 North America Cholesterol Management Devices by Countries
      • 6.1.1 North America Cholesterol Management Devices Sales by Countries
      • 6.1.2 North America Cholesterol Management Devices Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cholesterol Management Devices by Product
    • 6.3 North America Cholesterol Management Devices by End User

    7 Europe

    • 7.1 Europe Cholesterol Management Devices by Countries
      • 7.1.1 Europe Cholesterol Management Devices Sales by Countries
      • 7.1.2 Europe Cholesterol Management Devices Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cholesterol Management Devices by Product
    • 7.3 Europe Cholesterol Management Devices by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cholesterol Management Devices by Countries
      • 8.1.1 Asia Pacific Cholesterol Management Devices Sales by Countries
      • 8.1.2 Asia Pacific Cholesterol Management Devices Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cholesterol Management Devices by Product
    • 8.3 Asia Pacific Cholesterol Management Devices by End User

    9 Central & South America

    • 9.1 Central & South America Cholesterol Management Devices by Countries
      • 9.1.1 Central & South America Cholesterol Management Devices Sales by Countries
      • 9.1.2 Central & South America Cholesterol Management Devices Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cholesterol Management Devices by Product
    • 9.3 Central & South America Cholesterol Management Devices by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cholesterol Management Devices by Countries
      • 10.1.1 Middle East and Africa Cholesterol Management Devices Sales by Countries
      • 10.1.2 Middle East and Africa Cholesterol Management Devices Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cholesterol Management Devices by Product
    • 10.3 Middle East and Africa Cholesterol Management Devices by End User

    11 Company Profiles

    • 11.1 Boston Scientific Corporation
      • 11.1.1 Boston Scientific Corporation Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Boston Scientific Corporation Cholesterol Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Boston Scientific Corporation Cholesterol Management Devices Products Offered
      • 11.1.5 Boston Scientific Corporation Recent Development
    • 11.2 Medtronic
      • 11.2.1 Medtronic Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Medtronic Cholesterol Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Medtronic Cholesterol Management Devices Products Offered
      • 11.2.5 Medtronic Recent Development
    • 11.3 St. Jude Medical
      • 11.3.1 St. Jude Medical Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 St. Jude Medical Cholesterol Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 St. Jude Medical Cholesterol Management Devices Products Offered
      • 11.3.5 St. Jude Medical Recent Development
    • 11.4 Koninklijke Philips
      • 11.4.1 Koninklijke Philips Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Koninklijke Philips Cholesterol Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Koninklijke Philips Cholesterol Management Devices Products Offered
      • 11.4.5 Koninklijke Philips Recent Development
    • 11.5 Roche Diagnostics
      • 11.5.1 Roche Diagnostics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Roche Diagnostics Cholesterol Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Roche Diagnostics Cholesterol Management Devices Products Offered
      • 11.5.5 Roche Diagnostics Recent Development
    • 11.6 Abbott
      • 11.6.1 Abbott Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Abbott Cholesterol Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Abbott Cholesterol Management Devices Products Offered
      • 11.6.5 Abbott Recent Development
    • 11.7 Alere
      • 11.7.1 Alere Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Alere Cholesterol Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Alere Cholesterol Management Devices Products Offered
      • 11.7.5 Alere Recent Development
    • 11.8 Sorin Group
      • 11.8.1 Sorin Group Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Sorin Group Cholesterol Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Sorin Group Cholesterol Management Devices Products Offered
      • 11.8.5 Sorin Group Recent Development
    • 11.9 BIOTRONIK
      • 11.9.1 BIOTRONIK Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 BIOTRONIK Cholesterol Management Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 BIOTRONIK Cholesterol Management Devices Products Offered
      • 11.9.5 BIOTRONIK Recent Development

    12 Future Forecast

    • 12.1 Cholesterol Management Devices Market Forecast by Regions
      • 12.1.1 Global Cholesterol Management Devices Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cholesterol Management Devices Revenue Forecast by Regions 2019-2025
    • 12.2 Cholesterol Management Devices Market Forecast by Product
      • 12.2.1 Global Cholesterol Management Devices Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cholesterol Management Devices Revenue Forecast by Product 2019-2025
    • 12.3 Cholesterol Management Devices Market Forecast by End User
    • 12.4 North America Cholesterol Management Devices Forecast
    • 12.5 Europe Cholesterol Management Devices Forecast
    • 12.6 Asia Pacific Cholesterol Management Devices Forecast
    • 12.7 Central & South America Cholesterol Management Devices Forecast
    • 12.8 Middle East and Africa Cholesterol Management Devices Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cholesterol Management Devices Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Cholesterol is a type of lipid molecule, which is biosynthesized by all animal cells as it is an essential structural component of the cells. Cholesterol management devices are used to determine a lipoprotein profile and to measure total cholesterol content, high-density lipoprotein (HOL), low-density lipoprotein (LDL), triglycerides, and other fatty substances found in the human body.
      The global cholesterol management devices market is driven by increasing obese and overweight population base. According to the World Health Organization (2014), worldwide, more than 1.9 billion adults over 18 years were overweight of which over 600 million were obese. Less physical activity due to the desk-bound nature of many forms of work, changing modes of transportation, government support for the research and development, and increasing urbanization have fueled the growth of the market. However, lack of awareness among the people may slow the growth of the market.
      The global Cholesterol Management Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cholesterol Management Devices market based on company, product type, end user and key regions.

      This report studies the global market size of Cholesterol Management Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cholesterol Management Devices in these regions.
      This research report categorizes the global Cholesterol Management Devices market by top players/brands, region, type and end user. This report also studies the global Cholesterol Management Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Boston Scientific Corporation
      Medtronic
      St. Jude Medical
      Koninklijke Philips
      Roche Diagnostics
      Abbott
      Alere
      Sorin Group
      BIOTRONIK

      Market size by Product
      Monitors
      Wrist Monitors
      Small Portable Instruments
      Meters
      Wireless Systems
      Market size by End User
      Home Healthcare
      Hospitals
      Clinics

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Cholesterol Management Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Cholesterol Management Devices market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Cholesterol Management Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Cholesterol Management Devices submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Cholesterol Management Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cholesterol Management Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now